Ausgabe 2/2013
Inhalt (22 Artikel)
Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation
D. L. Eizirik, M. Miani, A. K. Cardozo
Volume of supervised exercise training impacts glycaemic control in patients with type 2 diabetes: a systematic review with meta-regression analysis
D. Umpierre, P. A. B. Ribeiro, B. D. Schaan, J. P. Ribeiro
Worse glycaemic control in LADA patients than in those with type 2 diabetes, despite a longer time on insulin therapy
C. D. Andersen, L. Bennet, L. Nyström, U. Lindblad, E. Lindholm, L. Groop, O. Rolandsson
A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus
S. S. Roscioni, D. de Zeeuw, M. E. Hellemons, H. Mischak, P. Zürbig, S. J. L. Bakker, R. T. Gansevoort, H. Reinhard, F. Persson, M. Lajer, P. Rossing, H. J. Lambers Heerspink
Associations between longevity of parents and glucose regulation in their offspring: the KORA S4/F4 Study
B. Kowall, A. Peters, B. Thorand, W. Rathmann, C. Meisinger
Prediction and classification of cardiovascular disease risk in older adults with diabetes
K. J. Mukamal, J. R. Kizer, L. Djoussé, J. H. Ix, S. Zieman, D. S. Siscovick, C. T. Sibley, R. P. Tracy, A. M. Arnold
Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS)
J. Lindström, M. Peltonen, J. G. Eriksson, P. Ilanne-Parikka, S. Aunola, S. Keinänen-Kiukaanniemi, M. Uusitupa, J. Tuomilehto
Effect of time of day and fasting duration on measures of glycaemia: analysis from the Whitehall II Study
A. Hulmán, K. Færch, D. Vistisen, J. Karsai, T. A. Nyári, A. G. Tabák, E. J. Brunner, M. Kivimäki, D. R. Witte
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes
A. Albrechtsen, N. Grarup, Y. Li, T. Sparsø, G. Tian, H. Cao, T. Jiang, S. Y. Kim, T. Korneliussen, Q. Li, C. Nie, R. Wu, L. Skotte, A. P. Morris, C. Ladenvall, S. Cauchi, A. Stančáková, G. Andersen, A. Astrup, K. Banasik, A. J. Bennett, L. Bolund, G. Charpentier, Y. Chen, J. M. Dekker, A. S. F. Doney, M. Dorkhan, T. Forsen, T. M. Frayling, C. J. Groves, Y. Gui, G. Hallmans, A. T. Hattersley, K. He, G. A. Hitman, J. Holmkvist, S. Huang, H. Jiang, X. Jin, J. M. Justesen, K. Kristiansen, J. Kuusisto, M. Lajer, O. Lantieri, W. Li, H. Liang, Q. Liao, X. Liu, T. Ma, X. Ma, M. P. Manijak, M. Marre, J. Mokrosiński, A. D. Morris, B. Mu, A. A. Nielsen, G. Nijpels, P. Nilsson, C. N. A. Palmer, N. W. Rayner, F. Renström, R. Ribel-Madsen, N. Robertson, O. Rolandsson, P. Rossing, T. W. Schwartz, P. E. Slagboom, M. Sterner, M. Tang, L. Tarnow, T. Tuomi, E. van’t Riet, N. van Leeuwen, T. V. Varga, M. A. Vestmar, M. Walker, B. Wang, Y. Wang, H. Wu, F. Xi, L. Yengo, C. Yu, X. Zhang, J. Zhang, Q. Zhang, W. Zhang, H. Zheng, Y. Zhou, D. Altshuler, L. M. ‘t Hart, P. W. Franks, B. Balkau, P. Froguel, M. I. McCarthy, M. Laakso, L. Groop, C. Christensen, I. Brandslund, T. Lauritzen, D. R. Witte, A. Linneberg, T. Jørgensen, T. Hansen, J. Wang, R. Nielsen, O. Pedersen
Functional relevance of genes implicated by obesity genome-wide association study signals for human adipocyte biology
F. Bernhard, K. Landgraf, N. Klöting, A. Berthold, P. Büttner, D. Friebe, W. Kiess, P. Kovacs, M. Blüher, A. Körner
Common variant in the HMGA2 gene increases susceptibility to nephropathy in patients with type 2 diabetes
S. Alkayyali, M. Lajer, H. Deshmukh, E. Ahlqvist, H. Colhoun, B. Isomaa, P. Rossing, L. Groop, V. Lyssenko
Small-molecule inhibitors of the cystic fibrosis transmembrane conductance regulator increase pancreatic endocrine cell development in rat and mouse
S. Zertal-Zidani, K. Busiah, A. Edelman, M. Polak, R. Scharfmann
The human L-type calcium channel Cav1.3 regulates insulin release and polymorphisms in CACNA1D associate with type 2 diabetes
T. M. Reinbothe, S. Alkayyali, E. Ahlqvist, T. Tuomi, B. Isomaa, V. Lyssenko, E. Renström
Adaptive changes of human islets to an obesogenic environment in the mouse
S. Gargani, J. Thévenet, J. E. Yuan, B. Lefebvre, N. Delalleau, V. Gmyr, T. Hubert, A. Duhamel, F. Pattou, J. Kerr-Conte
Syntaxin-3 regulates newcomer insulin granule exocytosis and compound fusion in pancreatic beta cells
D. Zhu, E. Koo, E. Kwan, Y. Kang, S. Park, H. Xie, S. Sugita, H. Y. Gaisano
Oestrogens improve human pancreatic islet transplantation in a mouse model of insulin deficient diabetes
S. Liu, G. Kilic, M. S. Meyers, G. Navarro, Y. Wang, J. Oberholzer, F. Mauvais-Jarvis
Human blood outgrowth endothelial cells improve islet survival and function when co-transplanted in a mouse model of diabetes
V. Coppens, Y. Heremans, G. Leuckx, K. Suenens, D. Jacobs-Tulleneers-Thevissen, K. Verdonck, T. Lahoutte, A. Luttun, H. Heimberg, N. De Leu
Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial
K. C. Herold, S. E. Gitelman, S. M. Willi, P. A. Gottlieb, F. Waldron-Lynch, L. Devine, J. Sherr, S. M. Rosenthal, S. Adi, M. Y. Jalaludin, A. W. Michels, J. Dziura, J. A. Bluestone
Identification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor γ (PPARγ) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetes
W. Zheng, X. Feng, L. Qiu, Z. Pan, R. Wang, S. Lin, D. Hou, L. Jin, Y. Li
cAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis
A.-K. Min, J. Y. Jeong, Y. Go, Y.-K. Choi, Y.-D. Kim, I.-K. Lee, K.-G. Park
Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes
Z. F. Kang, Y. Deng, Y. Zhou, R. R. Fan, J. C. N. Chan, D. R. Laybutt, J. Luzuriaga, G. Xu